Your browser doesn't support javascript.
loading
Prevalence and clinical characteristics of autoimmune liver disease in hospitalized patients with cirrhosis and acute decompensation in China.
Shen, Zi-Xuan; Wu, Dan-Dan; Xia, Jie; Wang, Xian-Bo; Zheng, Xin; Huang, Yan; Li, Bei-Ling; Meng, Zhong-Ji; Gao, Yan-Hang; Qian, Zhi-Ping; Liu, Feng; Lu, Xiao-Bo; Shang, Jia; Yan, Hua-Dong; Zheng, Yu-Bao; Gu, Wen-Yi; Zhang, Yan; Wei, Jian-Yi; Tan, Wen-Ting; Hou, Yi-Xin; Zhang, Qun; Xiong, Yan; Zou, Cong-Cong; Chen, Jun; Huang, Ze-Bing; Jiang, Xiu-Hua; Luo, Sen; Chen, Yuan-Yuan; Gao, Na; Liu, Chun-Yan; Yuan, Wei; Mei, Xue; Li, Jing; Li, Tao; Zhou, Xin-Yi; Deng, Guo-Hong; Chen, Jin-Jun; Ma, Xiong; Li, Hai.
Afiliação
  • Shen ZX; Department of Gastroenterology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
  • Wu DD; Shanghai Institute of Digestive Disease, Key Laboratory of Gastroenterology and Hepatology, Chinese Ministry of Health, Shanghai Jiao Tong University, Shanghai 200001, China.
  • Xia J; Department of Gastroenterology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
  • Wang XB; Shanghai Institute of Digestive Disease, Key Laboratory of Gastroenterology and Hepatology, Chinese Ministry of Health, Shanghai Jiao Tong University, Shanghai 200001, China.
  • Zheng X; Department of Infectious Diseases, Southwest Hospital, The Third Military Medical University (Army Medical University), Chongqing 400038, China.
  • Huang Y; Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100102, China.
  • Li BL; Department of Infectious Diseases, Institute of Infection and Immunology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, Hubei Province, China.
  • Meng ZJ; Department of Infectious Diseases, Hunan Key Laboratory of Viral Hepatitis, Xiangya Hospital, Central South University, Changsha 410008, Hunan Province, China.
  • Gao YH; Hepatology Unit, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong Province, China.
  • Qian ZP; Department of Infectious Disease, Taihe Hospital, Hubei University of Medicine, Shiyan 430418, Hubei Province, China.
  • Liu F; Department of Hepatology, The First Hospital of Jilin University, Changchun 130031, Jilin Province, China.
  • Lu XB; Department of Liver Intensive Care Unit, Shanghai Public Health Clinical Centre, Fudan University, Shanghai 201508, China.
  • Shang J; Tianjin Institute of Hepatology, Nankai University Second People's Hospital, Tianjin 300102, China.
  • Yan HD; Department of Infectious Diseases and Hepatology, The Second Hospital of Shandong University, Jinan 250033, Shandong Province, China.
  • Zheng YB; Infectious Disease Center, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, Xinjiang, China.
  • Gu WY; Department of Infectious Diseases, Henan Provincial People's Hospital, Zhengzhou 450003, Henan Province, China.
  • Zhang Y; Department of Infectious Diseases, Hwamei Hospital, The Second Hospital of Ningbo, University of Chinese Academy of Sciences, Ningbo 315153, Zhejiang Province, China.
  • Wei JY; Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, Guangdong Province, China.
  • Tan WT; Department of Gastroenterology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
  • Hou YX; Shanghai Institute of Digestive Disease, Key Laboratory of Gastroenterology and Hepatology, Chinese Ministry of Health, Shanghai Jiao Tong University, Shanghai 200001, China.
  • Zhang Q; Department of Gastroenterology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
  • Xiong Y; Shanghai Institute of Digestive Disease, Key Laboratory of Gastroenterology and Hepatology, Chinese Ministry of Health, Shanghai Jiao Tong University, Shanghai 200001, China.
  • Zou CC; Department of Gastroenterology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
  • Chen J; Shanghai Institute of Digestive Disease, Key Laboratory of Gastroenterology and Hepatology, Chinese Ministry of Health, Shanghai Jiao Tong University, Shanghai 200001, China.
  • Huang ZB; Department of Infectious Diseases, Southwest Hospital, The Third Military Medical University (Army Medical University), Chongqing 400038, China.
  • Jiang XH; Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100102, China.
  • Luo S; Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100102, China.
  • Chen YY; Department of Infectious Diseases, Institute of Infection and Immunology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, Hubei Province, China.
  • Gao N; Department of Infectious Diseases, Institute of Infection and Immunology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, Hubei Province, China.
  • Liu CY; Department of Infectious Diseases, Hunan Key Laboratory of Viral Hepatitis, Xiangya Hospital, Central South University, Changsha 410008, Hunan Province, China.
  • Yuan W; Hepatology Unit, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong Province, China.
  • Mei X; Department of Infectious Diseases, Hunan Key Laboratory of Viral Hepatitis, Xiangya Hospital, Central South University, Changsha 410008, Hunan Province, China.
  • Li J; Hepatology Unit, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong Province, China.
  • Li T; Department of Infectious Disease, Taihe Hospital, Hubei University of Medicine, Shiyan 430418, Hubei Province, China.
  • Zhou XY; Department of Infectious Disease, Taihe Hospital, Hubei University of Medicine, Shiyan 430418, Hubei Province, China.
  • Deng GH; Department of Hepatology, The First Hospital of Jilin University, Changchun 130031, Jilin Province, China.
  • Chen JJ; Department of Hepatology, The First Hospital of Jilin University, Changchun 130031, Jilin Province, China.
  • Ma X; Department of Liver Intensive Care Unit, Shanghai Public Health Clinical Centre, Fudan University, Shanghai 201508, China.
  • Li H; Department of Liver Intensive Care Unit, Shanghai Public Health Clinical Centre, Fudan University, Shanghai 201508, China.
World J Gastroenterol ; 28(31): 4417-4430, 2022 Aug 21.
Article em En | MEDLINE | ID: mdl-36159019
ABSTRACT

BACKGROUND:

Autoimmune liver disease (AILD) has been considered a relatively uncommon disease in China, epidemiological data for AILD in patients with cirrhosis and acute decompensation (AD) is sparse.

AIM:

To investigate the prevalence, outcome and risk factors for AILD in cirrhotic patients complicated with AD in China.

METHODS:

We collected data from patients with cirrhosis and AD from two prospective, multicenter cohorts in hepatitis B virus endemic areas. Patients were regularly followed up at the end of 28-d, 90-d and 365-d, or until death or liver transplantation (LT). The primary outcome in this study was 90-d LT-free mortality. Acute-on-chronic liver failure (ACLF) was assessed on admission and during 28-d hospitalization, according to the diagnostic criteria of the European Association for the Study of the Liver (EASL). Risk factors for death were analyzed with logistic regression model.

RESULTS:

In patients with cirrhosis and AD, the overall prevalence of AILD was 9.3% (242/2597). Prevalence of ACLF was significantly lower in AILD cases (14%) than those with all etiology groups with cirrhosis and AD (22.8%) (P < 0.001). Among 242 enrolled AILD patients, the prevalence rates of primary biliary cirrhosis (PBC), autoimmune hepatitis (AIH) and PBC-AIH overlap syndrome (PBC/AIH) were 50.8%, 28.5% and 12.0%, respectively. In ACLF patients, the proportions of PBC, AIH and PBC/AIH were 41.2%, 29.4% and 20.6%. 28-d and 90-d mortality were 43.8% and 80.0% in AILD-related ACLF. The etiology of AILD had no significant impact on 28-d, 90-d or 365-d LT-free mortality in patients with cirrhosis and AD in both univariate and multivariate analysis. Total bilirubin (TB), hepatic encephalopathy (HE) and blood urea nitrogen (BUN) were independent risk factors for 90-d LT-free mortality in multivariate analysis. The development of ACLF during hospitalization only independently correlated to TB and international normalized ratio.

CONCLUSION:

AILD was not rare in hospitalized patients with cirrhosis and AD in China, among which PBC was the most common etiology. 90-d LT-free mortality were independently associated with TB, HE and BUN.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encefalopatia Hepática / Hepatite Autoimune / Insuficiência Hepática Crônica Agudizada / Cirrose Hepática Biliar Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encefalopatia Hepática / Hepatite Autoimune / Insuficiência Hepática Crônica Agudizada / Cirrose Hepática Biliar Idioma: En Ano de publicação: 2022 Tipo de documento: Article